13.07.2015 Views

Measuring physical fitness in Persons with Severe/Profound ...

Measuring physical fitness in Persons with Severe/Profound ...

Measuring physical fitness in Persons with Severe/Profound ...

SHOW MORE
SHOW LESS
  • No tags were found...

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

studies. Randomized Controlled Trials (RCT’s) are considered to be the most reliable and valid wayto perform <strong>in</strong>tervention studies <strong>in</strong> various populations. Comparison between groups is thought toreflect differences <strong>in</strong> effect of the <strong>in</strong>terventions. The required sample size <strong>in</strong> RCT’s depends partlyon the variation between participants: a large variation calls for a larger sample size. Therefore,many studies <strong>in</strong>clude homogeneous groups. However, due to the variety of their co-morbidities,it is difficult to compose a homogeneous study population <strong>with</strong> sufficient power composedof persons <strong>with</strong> SPIMD. Neither is it possible to compose a large heterogeneous SPIMD studypopulation. As a consequence, both the experimental and control group will consist of participants<strong>with</strong> much variation <strong>in</strong> their co-morbidities, result<strong>in</strong>g <strong>in</strong> a wide array of responses to the same<strong>in</strong>tervention. In such circumstances detect<strong>in</strong>g significant effects of an <strong>in</strong>tervention is ratherdifficult. An anecdote from practical experience will illustrate this.To subject three participants <strong>with</strong> SPIMD to passive or assistive active movements, poweredexercise equipment (Shapemaster®, Barth Fidder, Shapemaster Benelux) was used. Thesemach<strong>in</strong>es are fitted <strong>with</strong> motors and gearboxes, and controlled by microchip technology. Themach<strong>in</strong>es automatically move selected levers and handles at pre-determ<strong>in</strong>ed speeds through apre-determ<strong>in</strong>ed range of motion. Each mach<strong>in</strong>e provides multi-function movements. The outcomemeasures are bodycomposition, muscle tone, heart rate, oxygen saturation and alertness [39]. Atthe <strong>in</strong>dividual level, relevant improvements were found for the different outcome measures.1. A woman of 38 years old, <strong>with</strong> profound ID, GMFCS level IV, no spasticity, totally bl<strong>in</strong>d,epilepsy, and be<strong>in</strong>g overweight, participated <strong>in</strong> the study. Her BMI before the <strong>in</strong>terventionwas 27.7 kg/cm 2 , after the <strong>in</strong>tervention 26.2 kg/cm 2 , which means a difference of 1.5 kg/cm 2 .Her waist circumference decreases from 89 cm, which means abdom<strong>in</strong>al obesitas, to 83 cm,which is <strong>in</strong>dicat<strong>in</strong>g ‘healthy weight but attention needed’ [7]. Oxygen saturation dur<strong>in</strong>g andafter mov<strong>in</strong>g on the mach<strong>in</strong>es <strong>in</strong>creased from 95% before the <strong>in</strong>tervention program, to 99 %after 20 weeks. However, muscle tone, alertness and hart frequency showed no differences.2. A girl of 17 years old, <strong>with</strong> profound ID, GMFCS level V, severe partially sighted, <strong>with</strong>spasticity, epilepsy and orthopedic defects also participated <strong>in</strong> the study. Her muscle tone<strong>in</strong> the legs decreased <strong>in</strong> 20 weeks <strong>with</strong> two po<strong>in</strong>ts on the six po<strong>in</strong>t scale of the ModifiedAshworth Scale. After every <strong>in</strong>crease <strong>in</strong> <strong>in</strong>tensity <strong>in</strong> a five weeks period, her heart rate<strong>in</strong>creased first one or two heart rate zones dur<strong>in</strong>g mov<strong>in</strong>g, but after three weeks, heart ratedecreased aga<strong>in</strong> to the first level. This might <strong>in</strong>dicate a tra<strong>in</strong><strong>in</strong>g effect. However, saturation,alertness, BMI and waist circumference showed no differences.3. A man of 43 years old, <strong>with</strong> profound ID, GMFCS level V, totally bl<strong>in</strong>d, spasticity, epilepsy,and orthopedic defects, also participated <strong>in</strong> the study. His muscle tone <strong>in</strong> both arms andlegs decreased <strong>in</strong> 20 weeks <strong>with</strong> one po<strong>in</strong>t on the six po<strong>in</strong>t scale of the Modified AshworthScale. Oxygen saturation dur<strong>in</strong>g mov<strong>in</strong>g on the mach<strong>in</strong>es <strong>in</strong>creased from 91% before the<strong>in</strong>tervention program, to 95 % after 20 weeks. BMI decreased after the <strong>in</strong>tervention <strong>with</strong>0.5 kg/cm 2 , but before and after the <strong>in</strong>tervention he already had a healthy BMI. Alertness<strong>in</strong>creased dur<strong>in</strong>g <strong>in</strong>tervention <strong>with</strong> one po<strong>in</strong>t on a four po<strong>in</strong>t scale [39]. However, heart rateshowed no differences dur<strong>in</strong>g and after the <strong>in</strong>tervention period.As shown, <strong>in</strong>dividuals benefit from the <strong>in</strong>tervention but not <strong>in</strong> the same way nor to the sameextent. Individual differences <strong>in</strong> characteristics of locomotor skills, visual impairment, comorbidities,and basel<strong>in</strong>e measurements of the outcome measures account for this result. Yet,there were benefits, albeit different ones for different subjects. In group comparison studies therelevant <strong>in</strong>dividual benefits can be overlooked. Consequently, next to traditional research designs,Chapter 9 | 145

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!